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Objective: This study investigated the effects on global cardiac function and myo-
cardial energetics of limiting progressive dilatation after infarction by means of a
woven polyester jacket cardiac support device. We hypothesized that placement of
the cardiac support device results in a decrease in myocardial wall stress and
improvement in cardiac function and myocardial energetics.
Methods: To investigate the effect of passive constraint on left ventricular function
and mechanics, a total of 10 sheep were studied with pressure-volume analysis and
magnetic resonance imaging. A baseline study was followed by the creation of an
anterior infarct. After 1 week, the animals underwent a second study. The cardiac
support device was then placed over the epicardium in 5 sheep; the remaining animals
served as controls. A terminal study was performed at 2 months after the infarct.
Results: The cardiac support device group at the terminal study exhibited a decrease
in end-diastolic volume (control 110.3  19.8 mL vs cardiac support device 67.6 
4.7 mL, P  .006) and an improved ejection fraction (control 15.5%  5.7% vs
cardiac support device 29.46%  4.42%, P  .008) relative to the control group.
Myocardial energetics were also enhanced in the cardiac support device group, as
evidenced by the significant improvements in potential energy (control 2015  503
mL · mm Hg/beat vs cardiac support device 885  220 mL · mm Hg/beat, P 
.006), efficiency (control 39.4%  13.6% vs cardiac support device 59.8%  8.5%,
P  .044), and oxygen consumption (control 0.072  0.013 mL O2/beat vs cardiac
support device 0.052  0.007 mL O2/beat, P  .034).
Conclusion: Passive constraint with the cardiac support device after infarct prevents
further remodeling and may stimulate reverse remodeling in heart failure secondary
to acute myocardial infarction. These results suggest that in human beings placement of
the cardiac support device after a large anterior myocardial infarction may be effective
in halting the remodeling process that often leads to end-stage heart failure. If proved
effective, placement of a cardiac support device after large heart attacks has the potential
to decrease the incidence of heart failure that results after large myocardial infarctions.
Ventricular remodeling after acute myocardial infarction (MI) ischaracterized by ventricular dilatation and functional impairmentassociated with an increased risk of heart failure.1-5 This process,characterized by significant architectural changes, such as loss offunctional cardiac units, myocyte hypertrophy, and interstitialcellular fibrosis6 resulting from myocardial loss by infarction,
remains incompletely understood. Recent studies suggest that left ventricular re-
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modeling is an important contributory event in the progres-
sion to end-stage congestive heart failure,7,8 and the degree
of left ventricular enlargement has been identified as being
associated with an unfavorable clinical outcome.9
The progressive deterioration in global cardiac function
after MI is directly related to an increase in wall stress,
which increases the workload of the left ventricle. Subse-
quently the heart enters into a positive feedback loop of
progressive dysfunction that ultimately leads to end-stage
heart failure. Pharmacologic therapy after MI, such as the
use of -blockers and angiotensin-converting–enzyme in-
hibitors, has been associated with significant improvement
in cardiovascular mortality by curbing the deleterious ef-
fects of ventricular remodeling.10-12
In this study we investigated the effects on global cardiac
function and myocardial energetics of mechanically limiting
progressive myocardial dilatation after infarction by means
of a bidirectional woven polyester jacket (Acorn Cardiac
Support Device; Acorn Cardiovascular, Inc, St Paul, Minn).
We hypothesized that placement of the cardiac support
device (CSD) after infarction would result in a decrease in
myocardial wall stress, with subsequent improvements in
global cardiac function and myocardial energetics. Mag-
netic resonance imaging (MRI) and pressure-volume anal-
ysis (PVA) were used to investigate the effects of passive
ventricular constraint in an ovine model of acute MI.
Materials and Methods
All animals used in this study received care in compliance with the
Guide for Care and Use of Laboratory Animals prepared by the
Institute of Laboratory Animal Resources, National Research
Council, and published by the National Academy Press, revised
1996. The investigation was approved by the institutional animal
care and use committee.
Study Design
To investigate the effect of limiting dilatation on myocardial
function and energetics, a total of 10 Dorset sheep were studied
with PVA and MRI. The experimental protocol for this study
consisted of performing baseline PVA and MRI studies, followed
by the creation of a transmural anterior wall MI. This was per-
formed through a left thoracotomy by ligating the left anterior
descending diagonal arteries.13 After a 1-week recovery period,
the animals underwent PVA and MRI studies again and were then
randomly assigned to one of two groups, CSD or control. The
custom polyester CSD was placed over the ventricular epicardium
in 5 sheep through the same thoracotomy used for infarct creation.
All animals received no further medical or surgical intervention for
the duration of the study. Terminal PVA and MRI studies were
performed at the 2-month postinfarct time point in both the control
and CSD groups.
Anesthesia
One hour before surgery the animals were medicated with 1 mg/kg
acepromazine and 0.001 mg/kg glycopyrrolate (INN glycopyrro-
nium bromide). General anesthesia was induced with ketamine (10
mg/kg) and diazepam (0.5 mg/kg). Endotracheal intubation was
performed, and the anesthesia was maintained with a mixture of
1% to 2% isoflurane in oxygen delivered by a time-cycled venti-
lator with a tidal volume of 20 mL/kg. Anesthesia was continu-
ously adjusted and monitored to maintain a constant physiologic
state in the animals. Postoperative analgesia consisted of flunixin
meglumine (2 mg/kg) and buprenorphine (2 g/kg) once imme-
diately after extubation and every 4 hours for 48 hours. General
anesthesia was used for all the surgical procedures and for the
duration of the MRI studies.
Animal Model
The infarct model used in this study was originally characterized
by Edmunds and colleagues13 at the University of Pennsylvania.
The heart was exposed through a left thoracotomy through the fifth
interspace with a partial fifth rib resection. On opening of the
pericardium, the coronary anatomy was inspected to determine the
vessels to be ligated. The criterion for ligation was any diagonal or
obtuse margin vessel that supplied the anterior portion of the
myocardium, excluding the left anterior descending coronary ar-
tery. Before ligation, the animals received a bolus of lidocaine as
prophylaxis and were started on infusions of lidocaine and epi-
nephrine. Systolic blood pressure was maintained at 80 mm Hg
throughout the procedure by means of successive bolus doses of
phenylephrine. The vessels were then ligated with 3-0 Prolene
(Ethicon, Inc, Somerville, NJ) suture. The chest remained open for
an additional 45 minutes while the animal’s vital signs and elec-
trocardiogram were continuously monitored to ensure that the
animal’s condition was stable. After this period, in the 5 animals
randomly assigned to the CSD group the pericardium was closed
to minimize adhesions to the myocardium, whereas the pericar-
dium in the remaining animals was left open. The incision was
closed in layers, and a chest tube was placed to drain the chest and
evacuate the pneumothorax (the chest tube was removed once the
animal became ambulatory). The animal’s vital signs and electro-
cardiogram were closely monitored for the initial 24-hour postop-
erative period before the animal was sent back to the colony.
CSD Placement
One week after infarction, the CSD was placed in 5 animals. This
device is made of a custom-designed polyester weave that limits
circumferential dilatation but allows longitudinal lengthening.
With the animal under general anesthesia, the original thoracotomy
was reopened and extended dorsally to allow resection of the
remainder of the fifth rib. The pericardium was reopened to allow
placement of the CSD, which was accomplished by sliding the
device over the epicardium, up to the level of the atrioventricular
junction. Prolene sutures (4-0) were placed along the base of heart
starting on the posterior surface and working around anteriorly,
with a total of between 8 and 10 sutures depending on the size of
the heart. The excess material was gathered up along a line parallel
with the long axis of the heart, excised, and resewn to ensure a
snug final fit. The thoracotomy was closed as before, and a chest
tube placed to evacuate the pneumothorax (and again removed
when the animal became ambulatory). The animals received the
same postoperative recovery measures as they did after the cre-
ation of the infarct.
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PVA
PVA was conducted with the animal under anesthesia as follows.
A 7F multielectrode dual-field conductance catheter (Webster
Labs, Baldwin Park, Calif) and a 5F micromanometer-tipped cath-
eter (Millar Instruments, Inc, Houston, Tex) were placed under
fluoroscopic guidance along the long axis of the left ventricular
cavity through sterile cutdowns of the carotid and right femoral
artery. Similarly, 20-mL occlusion catheters (Applied Vascular,
Laguna Hills, Calif) were placed at the junction of the superior and
inferior venae cavae with the right atrium through the right jugular
and right femoral veins. A balloon-tipped pulmonary artery cath-
eter was placed through the left jugular vein. Volume measure-
ments were obtained with the conductance catheter technique.14-19
All hemodynamic signals and the electrocardiographic tracing
were processed with an analog amplifier (Gould Electronics Inc,
Eastlake, Ohio), digitized at 250 Hz, and stored on computer disk
for off-line analysis.
All data were collected with the ventilator held at end expira-
tion. For determination of the end-systolic and end-diastolic pres-
sure-volume relationships (ESPVR and EDPVR, respectively)20
and the preload-recruitable stroke work relationship (PRSW, the
slope of stroke work vs end-diastolic volume [EDV]),21 the 20-mL
balloons in the venae cavae were gradually and temporarily in-
flated to alter preload as described previously elsewhere.19 All
incisions were then closed primarily.
MRI
At baseline, 1 week, and 2 months after infarct, all animals
underwent imaging in a 1.5-T whole-body high-speed clinical MRI
system (GE Medical Systems, Milwaukee, Wis). Immediately after
the PVA study, the animals were transported, still under general
anesthesia, to the MRI unit. The left ventricular Millar catheter
remained in place for the duration of the MRI study to allow MRI
pressure-volume loops to be created by combining continuous left
ventricular pressure data with MRI volume data. All images were
cardiac and respiratory gated to ensure consistent spatial position-
ing of the heart during each acquisition. Tissue-tagged images in
the short-axis plane were acquired for this study.
The imaging parameters were as follows: field of view 22 cm,
TR/TE 8.8/2.2 ms, slice thickness 6 mm, interslice gap 0, tag
spacing 5 mm, 2 signal averages, and 6 to 8 k-space lines acquired
per cardiac frame (depending on heart rate). Images were acquired
in the short-axis plane with two 12.7-cm surface coils placed on
the left and right sides of the chest. The images were archived and
stored for off-line analysis.
Energetics
Indices of myocardial energetics,22 including pressure-volume
area (area bounded by the end-systolic elastance [Ees] and the
pressure-volume loop), external work (area circumscribed by the
pressure-volume loop), the potential energy (pressure-volume area
minus external work), and myocardial oxygen consumption were
obtained from combining the Ees obtained from the PVA with the
volumes obtained by MRI. Myocardial mechanical efficiency was
defined as the ratio of the external work to the total pressure-
volume area.
Statistics
Statistical tests were performed with commercial computer soft-
ware (SigmaStat; SPSS Inc, Chicago, Ill). All data are expressed as
mean  SD. Differences between time points within a group were
assessed by 1-way analysis of variance with repeated measures
followed by the multiple comparison method of Student-Newman-
Keuls. Quantitative results between the two groups at the terminal
time point were analyzed by t test.
Results
Representative MRI images of a control sheep and a CSD
sheep at the terminal time point are presented in Figure 1.
These images were acquired at the midventricular level and
at the end-diastole and end-systole points in the cardiac
cycle. The images indicate that the CSD animal was less
dilated and had a greater ejection fraction (EF) relative to the
control sheep. In addition, the thinned area (as delineated by
the arrows) appears to be less significant in the CSD animal.
Volume data obtained by MRI reveal that cardiac func-
tion deteriorated in the control group at the terminal time
point. EDV in the control animals increased throughout the
study, reaching significance (P  .045) at the terminal time
point relative to baseline (Figure 2). At the same time, EF
decreased throughout the study, reaching significance at the
terminal time point relative to both the baseline (P  .01)
and the 1-week post infarct time points (P  .01; Figure 3).
All other volume parameters (stroke volume P  .12, car-
diac output P  .11, and end-systolic volume [ESV]) de-
generated at the terminal time point relative to 1 week after
infarct, with only ESV achieving significance (P  .005;
Table 1).
In the CSD group, EDV exhibited no significant change
throughout the study, whereas EF decreased significantly
from baseline to terminal but not from one-week to termi-
nal. Stroke volume (P  .23) and cardiac output (P  .21)
trended downward at the terminal time point, whereas ESV
(P  .67) remained virtually unchanged (Table 1).
A comparison of the volume data at the terminal time
point between the two groups showed that EDV and ESV
were significantly reduced and EF was significantly im-
proved in the CSD group. In addition, end-diastolic mass
was significantly greater in the CSD group at 2 months after
infarct (Table 1). This observed increase in mass is thought
to be due to the CSD and adhesions, which cannot be
differentiated from myocardium by MRI.
The load-independent indices Ees (Figure 4) and PRSW
(P  .17; Table 1) obtained by PVA trended downward in
the control group, with Ees achieving significance (P 
.032). The remaining load-dependent indices dP/dtmax (P 
.051), dP/dtmin (P  .051), and end-diastolic pressure (P 
.13) all trended toward decreased function but did not reach
significance (Table 1).
In the CSD group the load-independent indices (Ees P 
.3, PRSW P  .2) trended upward at the terminal point
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relative to the 1-week point. In addition, dP/dtmin (P  .13)
improved at the terminal time point but did not achieve
significance. A comparison of the two groups at the terminal
time point demonstrated that Ees was significantly (P 
.002) greater in the CSD group.
MRI-generated composite pressure-volume loops for the
control and CSD groups are shown in Figure 5. The com-
posite loops were generated by averaging the pressure-
volume data at end-diastole, end-systole, end–isovolumic
contraction, and end–isovolumic relaxation points for each
animal in each group. In the control group there is a shift to
the right from baseline to 1 week and from 1 week to
terminal, indicating an increase in EDV and ESV. The CSD
group exhibits the same rightward shift from baseline to 1
week, but from 1 week to terminal there is no shift in
volume, indicting that the CSD has halted the dilatation.
The myocardial energetics data demonstrate that the po-
tential energy (P  .028) and efficiency (P  .031) deteri-
orated significantly relative to the baseline levels in the
control group, whereas there were no significant changes in
the CSD group (Table 1). Relative to the control group, at
the terminal time point the CSD group had significantly
lower potential energy (P  .006), PVA (P  .037), and
oxygen consumption (P  .034) and had an improved
myocardial efficiency (P  .044; Figure 6).
Discussion
Dynamic cardiomyoplasty can be considered the precursor
of passive prosthetic ventricular constraint used as a therapy
for end-stage heart failure. Though originally conceived as
a means by which a patient’s own skeletal muscle would
contract around the heart to augment stroke volume, animal
and clinical results suggested that the actual dynamic effect
was inconsistent and limited, despite highly consistent clin-
ical benefit. Studies in a canine model of chronic dilated
cardiomyopathy by Patel and coworkers23 suggested that
Figure 1. Representative short-axis MRI images of heart at level of midventricle. A, Control end-diastole. B, Control
end-systole. C, CSD end-diastole. D, CSD end-systole. Control animals (A, B) have greater EDV and ESV, larger
areas of thinned myocardium (arrows), and more abnormal geometry than CSD counterparts (C, D).
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the chronic hemodynamic benefit after cardiomyoplasty was
due to the passive effect of the skeletal muscle wrap around
the heart alone, apart from any dynamic effect. This “gir-
dling effect” of the conditioned muscle wrap was shown to
stabilize the remodeling process of heart failure, arresting
progressive deterioration of systolic and diastolic function.
This observation prompted the development of a prosthetic
jacket—the CSD—that would produce a girdling effect
similar to that of the skeletal muscle wrap. Passive contain-
ment by an Acorn CSD was first studied by Chaudry and
colleagues24 in a well-established animal model of chronic
dilated cardiomyopathy. They demonstrated that not only
did hearts treated with the CSD not enlarge further, they
actually decreased in volume and improved in function. In
Figure 2. Graph depicting EDV changes. EDV was increased significantly in control group between baseline and
2-month time point. EDV was decreased significantly between the control and CSD groups at terminal time point.
Dagger indicates P < .05 between baseline and 2-month time points; asterisk indicates P < .05 between control
and CSD groups.
Figure 3. Graph depicting ejection fraction (EF) changes between control and CSD groups at baseline, 1 week after
infarct, and 2 months after infarct. In control group there was significant decrease in ejection fraction between
baseline and 2 months and 1 week and 2 months. In CSD group there was significant decrease in ejection fraction
between baseline and 2-month time points. Finally, ejection fraction was increased significantly between control
and CSD groups at terminal time point. Double dagger indicates P < .05 between 1-week and 2-month time points;
dagger indicates P < .05 between baseline and 2-month time points; circle indicates P < .05 between baseline
and 2-month time points; asterisk indicates P < .05 between control and CSD groups.
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addition to evidence of reverse remodeling on a ventricular
level relative to control hearts, they further demonstrated
that there was reversal of remodeling on a cellular level
(single myocyte studies) and on a molecular level (a de-
crease in stretch proteins and improved calcium ion cy-
cling).24
TABLE 1. Load-dependent and load-independent PVA data, global function measures from MRI, and measures of
myocardial energetics
Control CSD
Baseline 1 wk Terminal Baseline 1 wk Terminal
PVA
Volume axis intercept (mL) 24.8 20.1 11.2 12.0 44.6 19.1*† 9.4 34.45 3.0 22.6 19.6 19.33
ESPVR correlation 0.991 0.005 0.991 .009 0.990 0.008 0.978 0.015 0.988 0.009 0.979 0.012
PRSW (mm Hg) 50.3 16.50 45.11 15.78 33.04 18.99 55.57 13.00 46.57 9.29 60.8 22.39
dP/dtmax (mm Hg/s) 1492 235 1457 434 1069 211 1407 404 1232 461 1538 355
dP/dtmin (mm Hg/s) 1813 359 1306 255 1252 213 1509 368 1179 385 1517 251
 (ms) 49.6 13.28 74.13 21.93 63.9 7.00 57.9 16.25 49.5 15.15 54.8 12.62
EDP (mm Hg) 5.25 1.86 13.09 1.26 10.54 2.24 5.39 2.19 8.92 1.3 9.83 3.7
Heart rate (beats/min) 97.6 9.73 104.8 10.98 105.1 14.10 94.6 13.01 107.2 8.98 111.2 9.86
MRI
End-diastolic mass (g) 106.4 11.3 112.6 25.23 108.5 13.8 112.2 14.2 114.7 18.4 144.07 4.9‡
Stroke volume (mL) 20.2 8.76 28.28 6.25 17.72 9.97 20.71 1.50 27.15 11.46 19.85 2.79
Cardiac output (mL/min) 2027 705 2856 875 1850 640 1923 273 2909 983 2213 234
End-systolic volume (mL) 36.15 9.78 57.5 18.48 91.44 11.56*† 30.81 11.70 45.42 9.94 47.77 5.63‡
Energetics
Potential energy (mL · mm
Hg/beat)
1024 345 1426 534 2015 503† 2149 1344 1526 1116 885 220‡
Efficiency (%) 60.8 12.0 59.6 4.84 39.4 13.6*† 46.6 10.1 60.1 10.1 59.8 8.5‡
Volume axis intercept was increased significantly in the control group between baseline and terminal and between 1 week and terminal. End-diastolic mass
was increased significantly between control and CSD groups at the 2-month time point. End-systolic volume was increased significantly between baseline
and terminal and between 1 week and terminal in the control group but was decreased significantly between the control and CSD groups at terminal.
Potential energy was increased significantly between baseline and terminal in the control group but was decreased significantly between control and CSD
groups at terminal. Efficiency was decreased significantly between baseline and 1 week and between 1 week and terminal in the control group, whereas
it was increased significantly between the control and CSD groups at terminal.
*P  .05 between baseline and terminal.
†P  .05 between 1 week and terminal.
‡P  .05 between control and CSD groups.
Figure 4. Graph depicting changes in end-systolic elastance (Ees). Elastance was decreased significantly in
control group between baseline and 2 months. Elastance was increased significantly between control and CSD
groups at 2-month time point. Dagger indicates P < .05 between baseline and 2-month time points; asterisk
indicates P < .05 between control and CSD groups.
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The first Acorn CSDs were placed in human beings in
Germany in 1999. Since that time nearly 100 patients with
dilated cardiomyopathies have had the CSD placed. So far
it has been shown to be safe. In the few patients followed up
for longer than 2 years, there have been no reports of
constriction developing or of other major device-related
complications.25 Adhesions after placement of a CSD
around the heart have in a few cases necessitated transplan-
tation, but in other cases adhesions have not been signifi-
cant. In all cases transplantation was performed success-
fully. The presence of a CSD would make future surgical
revascularization difficult. Although many patients have
shown significant improvement, efficacy has yet to be dem-
onstrated. There is an on-going prospective, randomized,
multi-institutional study in both the United States and Eu-
rope to study the effectiveness of the CSD in patients with
heart failure and dilated hearts.
This is the first study to indicate that passive ventricular
constraint with the Acorn CSD prevents progressive LV
dilatation after an acute MI. This is demonstrated by the fact
that left ventricular pressure-volume loops generated for the
control shifted rightward throughout the study, whereas
after placement of the CSD the loops stabilized (Figure 6).
This finding and other data presented in this study reveal
that the CSD has halted the progressive remodeling seen
after an acute MI. Further, the results also indicate that there
may be some degree of reverse remodeling, as evidenced by
an improvement in elastance and in the working conditions
of the heart.
In this study we also examined the effects of CSD
placement on myocardial energetics. At the terminal time
point the CSD group had increased contractility (Figure 4),
wasted less energy as heat, and consumed less oxygen. In
contrast, the control group contracted less well while using
more oxygen and wasting more energy as heat. Therefore
for a given level of external work (similar to stroke work),
the CSD group performed more efficiently and consumed
less oxygen (Figure 6).
An improvement in function occurred in the absence of
any evidence of restrictive or constrictive physiologic ef-
fect. This is supported by the diastolic function results
(Table 1). End-diastolic pressure trended upward in both
groups, and there was no significant difference between the
groups at the terminal time point. The load-dependent mea-
sure of relaxation dP/dtmin deteriorated in the control group
throughout the course of the study, whereas in the CSD
group this index improved at the terminal time point. The
time constant of relaxation () showed no significant differ-
ence between the two groups at the terminal time point.
The mechanism of action of the CSD is postulated to be
that it limits myocardial wall stress by stabilizing the ven-
tricular radius. The CSD may in fact not only limit but decrease
wall stress by “off loading” a portion of the stress to the CSD
(Figure 7). The sum of the forces without the CSD has the
myocardium solely opposing the internal pressure. With the
CSD in place, the same internal pressure is now opposed not
only by the myocardium but also by the CSD, thus reducing
the stress on the myocardium. This reduction in wall stress
may stimulate the process of reverse remodeling. In both the
chronic model of dilated cardiomyopathy and our model of
remodeling after an acute MI, it is hypothesized that the
CSD acts to decrease wall stress (global and regional). This
acts as the stimulus to limit progressive remodeling and
allows a degree of reverse remodeling.
The results of this study are consistent with a recent
animal study that used a patch of Marlex (Phillips Petro-
Figure 5. MRI-generated composite pressure-volume loops from
control (A) and CSD (B) animals. Rightward shift of loops in
control group demonstrates increase in EDV and ESV and dete-
rioration in cardiac function between baseline and terminal time
points. CSD loops show increase in volumes between baseline
and 1 week but stabilization in function (as shown by leftward
shift) at terminal time point.
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Figure 6. A, Stroke work (EW), at 2-month time point. B, Potential energy (PE, measure of heat loss from work) at
2-month time point. C, Efficiency (EFF) at 2-month time point. D, Oxygen consumption (VO2) at 2-month time point.
Potential energy and oxygen consumption were significantly decreased between control and CSD groups at
2-month time-point. Efficiency was significantly increased between control and CSD groups at 2-month time-point.
Asterisk indicates P < .05 between control and CSD groups.
Figure 7. Forces on cross-section of myocardium depicted without CSD (A) and with CSD (B). Sum of forces
without CSD results in internal pressure being opposed solely by stress in myocardium. With CSD placement
internal pressure is opposed by stress in myocardium and stress on CSD, thus reducing myocardial wall stress.
Assumes an isotropic homogeneous sphere at static equilibrium.
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leum Company, Bartlesville, Okla) mesh applied before the
creation of an infarct.26 Their findings were also attributed
to the limiting of myocardial wall stress, which they postu-
lated preserved the border zone to result in a stable, nonex-
panding infarct.
There are some limitations to this study that merit con-
sideration. The pericardium on the CSD sheep was closed
immediately after infarct to facilitate CSD placement the
next week, whereas the pericardium was left opened in the
control group. This does not correlate with the clinical
situation and theoretically may result in increased remodel-
ing in the control animals because pericardial restraint has
been removed. However, at 1 week after infarct there was
no statistical difference between the two groups, indicating
that closing the pericardium had no observable effect on
function and that both groups had remodeling to an equal
degree. Another limitation is the lack of a sham operation at
1 week on the control animals. The effect of a sham oper-
ation, if anything, however, would be a negative one on the
control group. Additional studies are also need to assess the
efficacy of the CSD for longer periods in animals with
advanced heart failure secondary to acute MI and to more
clearly elucidate the cellular and molecular mechanism be-
hind passive constraint and its benefit in heart failure.
In conclusion, passive constraint with the CSD after
infarct prevents further remodeling and may stimulate re-
verse remodeling in sheep with heart failure secondary to
acute MI. These results suggest that in human beings place-
ment of the CSD after a large anterior MI may be effective
in halting the remodeling process that often leads to end-
stage heart failure. If proved effective, placement of a CSD
has the potential to decrease the incidence of heart failure
that results after large MIs, but the final determination of
whether these results can be extrapolated to human beings
must wait for a randomized, controlled trail.
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